Avadel Pharmaceuticals plc (AVDL)

Avadel Pharmaceuticals Revenue

In the year 2024, Avadel Pharmaceuticals had annual revenue of $169.12M with 504.79% growth. Avadel Pharmaceuticals had revenue of $50.41M in the quarter ending December 31, 2024, with 159.14% growth.

• Revenue (ttm): $169.12M
• Revenue Growth: +504.79%
• P/S Ratio: 4.84
• Revenue / Employee: $899,559
• Employees: 188
• Market Cap: 830.05M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	169.12M	141.15M	504.79%
Dec 31, 2023	27.96M	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-
Dec 31, 2020	22.33M	-36.88M	-62.28%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.